CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CVRX CVRx, Inc.

Pre-Mkt 08-28 04:51:51 EDT

3.04

-0.23

-7.03%

盘前3.04

+0.000.00%

04:30 EDT

High3.29	Low3.02	Vol448.87K
Open3.25	D1 Closing3.27	Amplitude8.26%
Mkt Cap80.99M	Tradable Cap61.34M	Total Shares26.64M
T/O1.40M	T/O Rate2.22%	Tradable Shares20.18M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CVRX","market":"US","secType":"STK","nameCN":"CVRx, Inc.","latestPrice":3.04,"timestamp":1787860800000,"preClose":3.27,"halted":0,"volume":448869,"hourTrading":{"tag":"盘前","latestPrice":3.04,"preClose":3.04,"latestTime":"04:30 EDT","volume":302,"amount":918.08,"timestamp":1787905839927,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07033639143730887,"floatShares":20176163,"shares":26641597,"eps":-1.9748,"marketStatus":"Pre-Mkt","change":-0.23,"latestTime":"08-28 04:51:51 EDT","open":3.25,"high":3.29,"low":3.02,"amount":1402722.0438267,"amplitude":0.082569,"askPrice":3.78,"askSize":100,"bidPrice":3.04,"bidSize":99,"shortable":3,"etf":0,"ttmEps":-1.9748,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787923800000},"marketStatusCode":1,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":3.04,"preHourTrading":{"tag":"盘前","latestPrice":3.04,"preClose":3.04,"latestTime":"04:30 EDT","volume":302,"amount":918.08,"timestamp":1787905839927,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.02,"preClose":3.04,"latestTime":"19:54 EDT","volume":3783,"amount":11552.6828,"timestamp":1787874870692,"change":-0.02,"changeRate":-0.006579,"amplitude":0.018783},"volumeRatio":0.4387263010817039,"impliedVol":1.3995,"impliedVolPercentile":0.768},"requestUrl":"/m/hq/s/CVRX/","defaultTab":"news","newsList":[{"id":"2662734358","title":"CVRx Says Board Reviews Options After Pointillist Letter, Sees Barostim Undervalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734358","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734358?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:04","pubTimestamp":1787659489,"startTime":"0","endTime":"0","summary":"CVRx says board reviews options after Pointillist letter, sees Barostim undervaluedCVRx responded to a Pointillist Family Office letter dated Aug. 24, 2026, citing ongoing evaluation of value-maximizi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL7lQqDJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","NDAQ","BK4585","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BKPKM429.USD","IE00BQXX3F31.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","CVRX","BK4112","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","BK4539","BK4588","IE00BQXX3D17.EUR","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","BCDF","LU2210149790.SGD","BK4082","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731774","title":"CVRx, Inc.: Board is Open to Constructive Engagement with All of Its Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731774?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0A0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CVRX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662310887","title":"CVRx, - Board Regularly Evaluates Options to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662310887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662310887?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732691","title":"CVRx Responds to Letter from Pointillist Family Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732691","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732691?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Aug.  25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (\"CVRx\"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neurom","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350401/0/en/cvrx-responds-to-letter-from-pointillist-family-office.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276025","title":"CVRx Shareholder Chernett Urges Board to Start Immediate Sale Process to Strategic Buyer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276025","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276025?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:32","pubTimestamp":1787574727,"startTime":"0","endTime":"0","summary":"CVRx shareholder Chernett urges board to start immediate sale process to strategic buyerPointillist Family Office founder Jorey Chernett, holding more than 5.5% of CVRx shares, urged the board to star","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL85xzBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727679","title":"Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727679?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574615,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276037","title":"Jorey Chernett: Calls on CVRx Board Initiate a Comprehensive Review of Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276037","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276037?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574615,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L06M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276799","title":"CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276799?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA9ZG5KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484758","title":"CVRx Price Target Cut to $5.00/Share from $13.00 by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484758","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484758?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:19","pubTimestamp":1786965540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CVRX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659636196","title":"CVRx COO Brent Binkowski Acquires 26,223 Common Shares Worth $76,416.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2659636196","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659636196?lang=en_us&edition=fundamental","pubTime":"2026-08-14 08:19","pubTimestamp":1786666772,"startTime":"0","endTime":"0","summary":"CVRx COO Brent Binkowski acquires 26,223 common shares worth $76,416.58CVRx Chief Operating Officer Brent Binkowski bought 26,223 common shares at a weighted average price of 2.91.His direct holdings ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1qdFHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CVRx COO Brent Binkowski Acquires 26,223 Common Shares Worth $76,416.58","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658925069","title":"CVRx - Robert John, Chief Revenue Officer, Employment Terminated Effective August 10, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658925069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658925069?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:10","pubTimestamp":1786446621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4480CX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4082","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992359","title":"CVRx CRO Robert John Exits; Paul Verrastro Named Interim Head of Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992359","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992359?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:06","pubTimestamp":1786446400,"startTime":"0","endTime":"0","summary":"CVRx CRO Robert John exits; Paul Verrastro named interim head of salesCVRx named Paul Verrastro interim head of sales, effective immediately, as it searches for a permanent successor.Chief Revenue Off","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL8C40C6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BKPKM429.USD","SG9999014021.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4585","BK4539","NDAQ","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","BCDF","BK4082","CVRX","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","BK4588","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994420","title":"CVRx Announces Sales Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994420","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994420?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446003,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUAHHTQ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657401316","title":"U.S. Stocks on the MOVE-Atlassian, Macerich, DoubleVerify","url":"https://stock-news.laohu8.com/highlight/detail?id=2657401316","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657401316?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:39","pubTimestamp":1786120748,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Atlassian, Macerich, DoubleVerifyAug 7 (Reuters)-Wall Street's main indexes were on track for strong weekly gains on Friday after data showed the U.S. economy unexpectedly","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL6N4440XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTW","SG","FSLR","RUN","SEDG","MB","XOM","ACMR","NEM","NET","BLSM","VLO","RMD","ATGL","MAC","XPOF","BNL","BETR","PN","STX","ABNB","INVX","YJ","TRGP","VATE","DOCS","MCHP","SEZL","ASIX","TTWO","UAA","RKT","TEAM","REPL","COHR","STEP","CVX","TTD","AU","WEN","WEAV","BLND","RWAY","ENPH","EXFY","FLR","LTGO","CVRX","DV","VST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657488236","title":"Piper Sandler Downgrades CVRx to Neutral From Overweight, Adjusts Price Target to $4 From $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2657488236","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657488236?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:25","pubTimestamp":1786101943,"startTime":"0","endTime":"0","summary":"CVRx (CVRX) has an average rating of overweight and mean price target of $9.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657102766","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2657102766","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657102766?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:18","pubTimestamp":1786101503,"startTime":"0","endTime":"0","summary":"CVRx  stock was down more than 43% premarket Friday, a day after the company posted Q2 financial results.TEN  shares were more than 35% lower after an over 252% rise in the prior session.The Trade Desk  stock was down 28% as multiple analyst downgrades followed the company's downbeat Q2 adjusted earnings and revenue.Health Catalyst  shares were down more than 26% after the company posted a Q2 loss and lower revenue.Bridger Aerospace Group  stock was down more than 24% after the company posted a wider Q2 loss and lower revenue.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XHLD","BK4009","BK4167","BK4548","BK4588","LU2357305700.SGD","LU1548497426.USD","BK4613","BK4082","BK4585","TTDU","BK4539","LU1720051017.SGD","BK4137","CVRX","BK4528","LU0348723411.USD","LU1720051108.HKD","BK4023","BAER","HCAT","TTD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657861008","title":"CVRx Shares Slide on Sales View Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2657861008","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657861008?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:15","pubTimestamp":1786101300,"startTime":"0","endTime":"0","summary":"Shares of CVRx fell after the company cut its sales outlook, citing a prolonged issue with one of its biggest customers.The stock sank 42% to $3.44 in premarket trading Friday. Through the previous close, shares were down 16% this year.The commercial-stage medical device company lowered its guidance for full-year revenue to a range of $58.0 million to $60.0 million, from $63.0 million to $67.0 million previously.It expects to record $13.5 million to $14.5 million in sales during the current third quarter, which would be below the $15.6 million analysts are projecting, according to FactSet.Chief Executive Kevin Hykes said he wasn't satisfied with the lower sales outlook. The guidance cut was driven by fewer sales territories than anticipated, lower sales force productivity and a prolonged challenge with one of CVRx's biggest players, he said.CVRx's loss was also wider than expected at 53 cents a share, compared with analysts' estimate of a 51-cent loss per share.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657048690","title":"U.S. Research Roundup-Airbnb, Expedia Group, Parker-Hannifin","url":"https://stock-news.laohu8.com/highlight/detail?id=2657048690","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657048690?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:25","pubTimestamp":1786087536,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-HannifinAug 7 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL4N4440HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COLL","CARG","COR","DV","CLOU","CVRX","ARLO","VDE","ARKG","TRUN","ADIG","CACI","DRLL","IAK","EMR","ERX","PH","CELT","EXPE","AIZ","DCO","CELH","DOCS","ALL","BETZ","CVX","AKAM","FISV","HAE","HUBS","ACA","ICUI","ABNB","FA","EXEL","NET","ETSY","BDX","TXG","DIG","EPAM","FLUT","CW","APP","CDRE","DDOG","GXPE","ALNT","FIVN","BMBL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657664722","title":"CVRx, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657664722","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657664722?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:17","pubTimestamp":1786061853,"startTime":"0","endTime":"0","summary":"CVRx, Inc. reports results for the quarter ended June 30 - Earnings SummaryCVRx, Inc.CVRX.OQreported a quarterly adjusted loss of 53 cents per share for the quarter ended June 30, higher than the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N44400W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657735665","title":"CVRx reports Q2 EPS (53c), consensus (52c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657735665","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657735665?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:16","pubTimestamp":1786050989,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $15.71M, consensus $15.55M. “We are pleased with the strong revenue growth and margin performance in the second quarter along wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cvrx-reports-q2-eps-53c-consensus-52c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cvrx-reports-q2-eps-53c-consensus-52c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVRX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cvrx.com","stockEarnings":[{"period":"1week","weight":0.0704},{"period":"1month","weight":-0.3859},{"period":"3month","weight":-0.4552},{"period":"6month","weight":-0.6275},{"period":"1year","weight":-0.5979},{"period":"ytd","weight":-0.5718}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0193},{"period":"6month","weight":0.1241},{"period":"1year","weight":0.1925},{"period":"ytd","weight":0.1308}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.093597},{"month":2,"riseRate":0.4,"avgChangeRate":-0.085377},{"month":3,"riseRate":0.2,"avgChangeRate":-0.089798},{"month":4,"riseRate":0.4,"avgChangeRate":-0.093376},{"month":5,"riseRate":0.2,"avgChangeRate":-0.166016},{"month":6,"riseRate":0.4,"avgChangeRate":0.146711},{"month":7,"riseRate":0.666667,"avgChangeRate":0.068189},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.086482},{"month":9,"riseRate":0.4,"avgChangeRate":-0.009886},{"month":10,"riseRate":0.8,"avgChangeRate":0.147336},{"month":11,"riseRate":0.6,"avgChangeRate":0.134494},{"month":12,"riseRate":0.6,"avgChangeRate":0.102852}],"exchange":"NASDAQ","name":"CVRx, Inc.","nameEN":"CVRx, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CVRx, Inc.(CVRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CVRx, Inc.,CVRX,CVRx, Inc.股票,CVRx, Inc.股票老虎,CVRx, Inc.股票老虎国际,CVRx, Inc.行情,CVRx, Inc.股票行情,CVRx, Inc.股价,CVRx, Inc.股市,CVRx, Inc.股票价格,CVRx, Inc.股票交易,CVRx, Inc.股票购买,CVRx, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CVRx, Inc.(CVRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction